Jason Cavalier serves as Executive at Lyra Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jason Cavalier has executed 2 insider transactions totaling $8.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 6, 2026 involved selling 769 shares valued at $2.6K.
Jason Cavalier currently holds 518,547 shares of Lyra Therapeutics, Inc. (LYRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Cavalier has been a net seller of LYRA stock. They have purchased $0 and sold $8.7K worth of shares.
Jason Cavalier's most recent insider trade was on Jan 6, 2026, when they sold 769 shares at $3.36 per share.
Get notified when new Form 4 filings are submitted
| $8.91 |
| Discretionary |